Proteomic-based analysis for identification of potential serum biomarkers in gallbladder cancer

Oncology Reports

Volumn 26, Issue 4, 2011, Pages 853-859

  Tan, Yi ^a   Ma, Shi Yin ^a,c   Wang, Fu Qiang ^d   Meng, Hai Ping ^a   Cuizhu, Mei ^b   Liu, Angen ^e   Wu, Hao Rong ^c  

^a First Affiliated Hospital   (China)

^b BENGBU MEDICAL COLLEGE   (China)

^c SUZHOU UNIVERSITY   (China)

^d NANJING MEDICAL UNIVERSITY   (China)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Gallbladder cancer; Haptoglobin; S100A10; Serum proteomics; Two dimensional gel electrophoresis

Indexed keywords

BIOLOGICAL MARKER; CYSTATIN B; HAPTOGLOBIN; PROFILIN; PROFILIN I; PROTEIN S 100; PROTEIN S 100A10; SUPEROXIDE DISMUTASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GALLBLADDER CANCER; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; SEPARATION TECHNIQUE; TWO DIMENSIONAL GEL ELECTROPHORESIS; VALIDATION PROCESS; WESTERN BLOTTING;

AGED; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 79960764480     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1353     Document Type: Article

References (30)

1. Lai EC and Lau WY: Aggressive surgical resection for carcinoma of gallbladder. ANZ J Surg 75: 441-444, 2005. (Pubitemid 40896909)
2. Bartlett DL, Fong Y, Fortner JG, Brennan MF and Blumgart LH: Long-term results after resection for gallbladder cancer. Ann Surg 224: 639-646, 1996.
3. D'Souza M, Joshi A, Desai D, Abraham P, Bhaduri A and Shah S: Highly elevated CA19-9 and gall bladder mass do not add up to cancer. Indian J Gastroenterol 25: 271-272, 2006.
4. Tseng MY, Liu SY, Chen HR, et al: Serine protease inhibitor (SERPIN) B1 promotes oral cancer cell motility and is overexpressed in invasive oral squamous cell carcinoma. Oral Oncol 45: 771-776, 2009.
5. Wang X, Chen Y, Han QB, et al: Proteomic identification of molecular targets of gambogic acid: role of stathmin in hepatocellular carcinoma. Proteomics 9: 242-253, 2009.
6. Chen JH, Ni RZ, Xiao MB, Guo JG and Zhou JW: Comparative proteomic analysis of differentially expressed proteins in human pancreatic cancer tissue. Hepatobiliary Pancreat Dis Int 8: 193-200, 2009.
7. Liu YF, Xiao ZQ, Li MX, et al: Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma. J Pathol 217: 54-64, 2009.
8. Zhu YF, Cui YG, Guo XJ, et al: Proteomic analysis of effect of hyperthermia on spermatogenesis in adult male mice. J Proteome Res 5: 2217-2225, 2006.
9. Feng JT, Liu YK, Song HY, et al: Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics 5: 4581-4588, 2005.
10. Chen R, Pan S, Brentnall TA and Aebersold R: Proteomic profiling of pancreatic cancer for biomarker discovery. Mol Cell Proteomics 4: 523-533, 2005. (Pubitemid 40590569)
11. Latterich M, Abramovitz M and Leyland-Jones B: Proteomics: new technologies and clinical applications. Eur J Cancer 44: 2737-2741, 2008.
12. Marenholz I, Lovering RC and Heizmann CW: An update of the S100 nomenclature. Biochim Biophys Acta 1763: 1282-1283, 2006.
13. Marenholz I, Heizmann CW and Fritz G: S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 322: 1111-1122, 2004. (Pubitemid 39164640)
14. Donato R: Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 60: 540-551, 2003.
15. Salama I, Malone PS, Mihaimeed F and Jones JL: A review of the S100 proteins in cancer. Eur J Surg Oncol 34: 357-364, 2008. (Pubitemid 351381290)
16. Rust R, Visser L, van der Leij J, et al: High expression of calcium-binding proteins, S100A10, S100A11 and CALM2 in anaplastic large cell lymphoma. Br J Haematol 131: 596-608, 2005. (Pubitemid 43899625)
17. Kanamori T, Takakura K, Mandai M, et al: Increased expression of calcium-binding protein S100 in human uterine smooth muscle tumours. Mol Hum Reprod 10: 735-742, 2004. (Pubitemid 39341596)
18. Luo RC, He XB, Cai HB and Li AM: Detection of serum S100 protein and tissue polypeptide-specific antigen for diagnosis and treatment of breast cancer. Di Yi Jun Yi Da Xue Xue Bao 24: 102-104, 2004.
19. Torres-Cabala C, Panizo-Santos A, Krutzsch HC, et al: Differential expression of S100C in thyroid lesions. Int J Surg Pathol 12: 107-115, 2004. (Pubitemid 38542482)
20. Cross SS, Hamdy FC, Deloulme JC and Rehman I: Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 46: 256-269, 2005. (Pubitemid 40343172)
21. Emberley ED, Murphy LC and Watson PH: S100 proteins and their influence on pro-survival pathways in cancer. Biochem Cell Biol 82: 508-515, 2004. (Pubitemid 39286966)
22. Zhang L, Fogg DK and Waisman DM: RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells. J Biol Chem 279: 2053-2062, 2004. (Pubitemid 38084477)
23. Dobryszycka W: Biological functions of haptoglobin - new pieces to an old puzzle. Eur J Clin Chem Clin Biochem 35: 647-654, 1997.
24. Baumann H, Jahreis GP and Morella KK: Interaction of cytokine and glucocorticoid-response elements of acute-phase plasma protein genes. Importance of glucocorticoid receptor level and cell type for regulation of the elements from rat alpha 1-acid glycoprotein and beta-fibrinogen genes. J Biol Chem 265: 22275-22281, 1990. (Pubitemid 120014296)
25. Ang IL, Poon TC, Lai PB, et al: Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach. J Proteome Res 5: 2691-2700, 2006. (Pubitemid 44595171)
26. Krueger KE and Srivastava S: Posttranslational protein modifi- cations: current implications for cancer detection, prevention, and therapeutics. Mol Cell Proteomics 5: 1799-1810, 2006. (Pubitemid 44688189)
27. Hudson LD and Enck RE: Hyperhaptoglobinemia and carcinoma of the gallbladder. Am J Gastroenterol 71: 284-286, 1979. (Pubitemid 9181000)
28. Kim IK, Lee JH, Kim HS, Kwon OJ and Shim BS: A novel function of haptoglobin: haptoglobin-haemoglobin complex induces apoptosis of hepatocarcinomatous Hep 3B cells. Scand J Clin Lab Invest 55: 529-535, 1995.
29. Kannagi R, Izawa M, Koike T, Miyazaki K and Kimura N: Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci 95: 377-384, 2004. (Pubitemid 38832679)
30. Fosslien E: Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis. Ann Clin Lab Sci 31: 325-348, 2001.